Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 1
2011 4
2012 4
2013 2
2014 3
2016 5
2017 10
2018 13
2019 5
2020 17
2021 10
2022 9
2023 15

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. Among authors: herrington wg. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
Haynes R, Judge PK, Staplin N, Herrington WG, Storey BC, Bethel A, Bowman L, Brunskill N, Cockwell P, Hill M, Kalra PA, McMurray JJV, Taal M, Wheeler DC, Landray MJ, Baigent C. Haynes R, et al. Among authors: herrington wg. Circulation. 2018 Oct 9;138(15):1505-1514. doi: 10.1161/CIRCULATIONAHA.118.034818. Circulation. 2018. PMID: 30002098 Free article. Clinical Trial.
Chronic kidney disease, heart failure and neprilysin inhibition.
Haynes R, Zhu D, Judge PK, Herrington WG, Kalra PA, Baigent C. Haynes R, et al. Among authors: herrington wg. Nephrol Dial Transplant. 2020 Apr 1;35(4):558-564. doi: 10.1093/ndt/gfz058. Nephrol Dial Transplant. 2020. PMID: 31028383 Free PMC article. Review.
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Herrington WG, Preiss D, Haynes R, von Eynatten M, Staplin N, Hauske SJ, George JT, Green JB, Landray MJ, Baigent C, Wanner C. Herrington WG, et al. Clin Kidney J. 2018 Dec;11(6):749-761. doi: 10.1093/ckj/sfy090. Epub 2018 Oct 25. Clin Kidney J. 2018. PMID: 30524708 Free PMC article. Review.
The authors reply.
Chapman D, Judge PK, Arnold T, Staplin N, Clark S, Haynes R, Moffat S, Herrington WG, Hill M. Chapman D, et al. Among authors: herrington wg. Kidney Int. 2023 Jul;104(1):201-202. doi: 10.1016/j.kint.2023.03.032. Kidney Int. 2023. PMID: 37349051 No abstract available.
Authors' Reply.
Herrington WG, Donovan K, Mihaylova B. Herrington WG, et al. J Am Soc Nephrol. 2018 Oct;29(10):2602-2603. doi: 10.1681/ASN.2018060612. Epub 2018 Jul 13. J Am Soc Nephrol. 2018. PMID: 30006418 Free PMC article. No abstract available.
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
Donovan K, Herrington WG, Paré G, Pigeyre M, Haynes R, Sardell R, Butterworth AS, Folkersen L, Gustafsson S, Wang Q, Baigent C, Mälarstig A, Holmes MV, Staplin N; on behalf of the SCALLOP Consortium. Donovan K, et al. Among authors: herrington wg. Clin J Am Soc Nephrol. 2023 Jan 1;18(1):17-27. doi: 10.2215/CJN.05080422. Clin J Am Soc Nephrol. 2023. PMID: 36719157 Free PMC article.
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
Inker LA, Collier W, Greene T, Miao S, Chaudhari J, Appel GB, Badve SV, Caravaca-Fontán F, Del Vecchio L, Floege J, Goicoechea M, Haaland B, Herrington WG, Imai E, Jafar TH, Lewis JB, Li PKT, Maes BD, Neuen BL, Perrone RD, Remuzzi G, Schena FP, Wanner C, Wetzels JFM, Woodward M, Heerspink HJL; CKD-EPI Clinical Trials Consortium. Inker LA, et al. Among authors: herrington wg. Nat Med. 2023 Jul;29(7):1867-1876. doi: 10.1038/s41591-023-02418-0. Epub 2023 Jun 17. Nat Med. 2023. PMID: 37330614
Ezetimibe: Likely to Be Beneficial For All.
Herrington WG, Preiss D, Armitage J. Herrington WG, et al. Circulation. 2018 Apr 10;137(15):1583-1584. doi: 10.1161/CIRCULATIONAHA.117.032819. Circulation. 2018. PMID: 29632152 No abstract available.
89 results